The global hip replacement implants market size was valued at USD 4.37 billion in 2025 and is projected to grow from USD 4.47 billion in 2026 to USD 5.39 billion by 2034, registering a CAGR of 2.35% during the forecast period from 2026 to 2034. North America dominated the hip replacement implants market with a market share of 39.2% in 2025.
Hip Replacement Implants refers to medical devices designed to replace damaged or deteriorated parts of the hip joint and restore mobility and joint function. These implants typically include components such as femoral stems, femoral heads, and acetabular cups made from metals, ceramics, or advanced polymers. Demand is increasing due to the rising prevalence of hip disorders, osteoarthritis, aging populations, and advancements in implant materials and surgical techniques.
Download a Free Sample To learn more about this report,
Growing Adoption of Ceramic-on-Polyethylene Bearing Systems
The hip replacement implants market is shifting toward bearing combinations designed to balance wear performance, durability, and clinical outcomes. Ceramic femoral heads paired with highly cross-linked polyethylene liners are increasingly used in primary total hip arthroplasty because they combine ceramic's wear characteristics with improvements in modern polyethylene materials. This is strengthening the importance of bearing-surface selection in implant design and procurement.
Increasing Use of Data-Driven and Robotic-Assisted Hip Replacement
The market is increasingly incorporating robotic assistance, surgical navigation, and registry-based outcome analysis into hip replacement procedures. These technologies support more consistent implant positioning and allow surgeons and healthcare systems to evaluate procedure and implant performance using larger clinical datasets. As outcome measurement becomes more important, implant manufacturers are increasingly competing on compatibility with digitally assisted surgical workflows.
Rising Hip Osteoarthritis Burden Supports Demand for Replacement Implants
Hip osteoarthritis is a major indication for total hip replacement, particularly among older adults experiencing persistent pain and impaired mobility. Increasing longevity and the growing prevalence of obesity are contributing to a larger population requiring treatment for advanced hip disease. When conservative management no longer provides adequate relief, total hip arthroplasty creates direct demand for femoral and acetabular implant components.
High Implant and Surgical Costs Can Limit Access to Hip Replacement
Hip replacement requires multiple implant components, specialized surgical facilities, imaging or navigation equipment, and postoperative care. The overall treatment cost can create affordability and reimbursement challenges, particularly in healthcare systems with constrained budgets. These financial considerations can delay elective procedures and restrict access to advanced implant systems.
Expansion of Implant Longevity and Advanced Bearing Technologies Creates Opportunities
Improving implant longevity creates opportunities for manufacturers to develop bearing surfaces and fixation technologies that reduce wear, instability, and revision requirements. Ceramic components, highly cross-linked polyethylene, and dual-mobility configurations provide manufacturers with avenues to address different patient profiles and surgical requirements. Longer-lasting implants are particularly valuable as younger and more active patients increasingly undergo joint replacement.
Ensuring Long-Term Implant Reliability and Managing Revision Risk Challenge Manufacturers
Hip implants must withstand repeated mechanical loading over many years while minimizing wear, loosening, dislocation, fracture, and other complications. Even established implant technologies can experience product-specific safety or performance issues, creating regulatory and reputational risks for manufacturers. Continuous post-market surveillance and long-term clinical evidence are therefore important for maintaining confidence in implant systems.
Total Hip Replacement Implants Segment Dominated the Market with 63.8% Share in 2025
The total hip replacement implants segment dominated the global hip replacement implants market with a 63.8% share in 2025, valued at USD 2.79 billion. Total hip replacement procedures are widely performed to restore mobility and relieve pain among patients with severe hip joint damage caused by osteoarthritis, fractures, and other degenerative conditions. Increasing demand for effective joint replacement solutions continues to support the segment's leading position.
Partial femoral head procedures are used for patients requiring replacement of only the damaged portion of the hip joint. Hip resurfacing provides an alternative approach for selected patients by preserving more of the natural bone, while revision hip procedures are gaining importance as the number of previously implanted patients requiring implant replacement or correction increases.
Request Customizationto receive a tailored report.
Metal on Polyethylene Segment Dominated the Market with 43.7% Share in 2025
The metal on polyethylene segment dominated the global hip replacement implants market with a 43.7% share in 2025, valued at USD 1.91 billion. Metal on polyethylene implants have been widely adopted due to their established clinical use, durability, and favorable performance across a broad range of hip replacement procedures. Their long-standing presence in orthopedic applications continues to support demand.
Ceramic on polyethylene implants are gaining adoption due to their wear characteristics and continued material advancements. Ceramic on ceramic implants offer additional options for selected patients, while metal on metal and ceramic on metal configurations serve specific clinical requirements. Ongoing innovation in implant materials is supporting the development of improved durability and performance.
Hospitals & Surgery Centers Segment Dominated the Market with 69.4% Share in 2025
The hospitals & surgery centers segment dominated the global hip replacement implants market with a 69.4% share in 2025, valued at USD 3.03 billion. Hospitals and specialized surgery centers perform a large proportion of hip replacement procedures due to their access to orthopedic surgeons, advanced surgical infrastructure, diagnostic capabilities, and postoperative care services. The availability of comprehensive treatment facilities supports their leading position.
Orthopedic clinics are increasingly contributing to market demand by providing specialized consultations, treatment planning, follow-up care, and selected surgical services. Other end users also contribute to implant utilization through specialized orthopedic and healthcare settings.
Speak to an Analystto discuss market opportunities.
North America dominated the Hip Replacement Implants Market with a market share of 39.2%, representing a value of USD 1.71 billion in 2025. The region is expected to register a CAGR of 5.4% during the forecast period. Growth is supported by the increasing prevalence of hip-related disorders, osteoarthritis, and age-associated musculoskeletal conditions. Rising demand for minimally invasive orthopedic procedures, advancements in implant materials and designs, and improvements in surgical techniques are further supporting market development. The presence of established healthcare infrastructure, specialized orthopedic centers, and growing adoption of technologically advanced implants is also contributing to regional demand.
The US represents a leading market for hip replacement implants, supported by advanced healthcare infrastructure, a large aging population, and high adoption of orthopedic surgical procedures. Increasing prevalence of osteoarthritis and other degenerative joint conditions is driving demand for hip replacement procedures. Manufacturers are increasingly developing implants with improved durability, biocompatibility, and anatomical designs to enhance patient outcomes. Growing adoption of minimally invasive and robotic-assisted orthopedic surgery is also supporting the use of advanced implant systems. Continued investments in orthopedic technologies and specialized surgical care are expected to support market development.
Canada's hip replacement implants market is supported by an aging population, increasing incidence of degenerative joint disorders, and expanding demand for orthopedic procedures. Healthcare providers are increasingly adopting advanced implant designs and surgical techniques aimed at improving patient mobility and recovery. Growing use of minimally invasive procedures and improvements in orthopedic care are contributing to market opportunities. Investments in healthcare infrastructure and specialized orthopedic services are also supporting access to joint replacement procedures. Continued focus on improving surgical outcomes and managing age-related musculoskeletal conditions is expected to sustain market demand.
Unlock Regional Insightsto access country-level data, & regional trends.
Europe accounted for a 30.1% share of the Hip Replacement Implants Market, reaching a value of USD 1.32 billion in 2025. The region is projected to grow at a CAGR of 6.5% during the forecast period. Market expansion is supported by an aging population, increasing prevalence of osteoarthritis, and growing demand for joint replacement procedures. European healthcare systems are increasingly adopting advanced implant materials, improved fixation technologies, and minimally invasive surgical techniques. Growing awareness of mobility-enhancing treatments and improvements in orthopedic healthcare are further supporting demand. Continued technological development and investments in specialized orthopedic services are expected to strengthen regional market growth.
Germany represents an important European market for hip replacement implants, supported by a well-developed healthcare system and strong orthopedic care infrastructure. The aging population and increasing prevalence of osteoarthritis and other joint disorders are contributing to demand for hip replacement procedures. Hospitals and orthopedic centers are increasingly adopting advanced implant designs and modern surgical technologies to improve patient outcomes. Growing use of minimally invasive procedures and computer-assisted or robotic surgical techniques is also creating opportunities. Continued investment in medical technology and orthopedic healthcare is expected to support market development.
The UK hip replacement implants market is supported by an aging population, increasing burden of hip-related disorders, and continued demand for orthopedic surgical procedures. Healthcare providers are increasingly focusing on improving surgical outcomes, implant longevity, and patient recovery. Adoption of advanced implant materials, minimally invasive techniques, and technology-assisted orthopedic procedures is contributing to market development. Growing demand for effective mobility-restoring treatments among older adults is also supporting the market. Continued improvements in orthopedic services and healthcare capacity are expected to create further opportunities for hip replacement implant manufacturers.
Asia Pacific accounted for a 22.4% market share, representing USD 0.98 billion in 2025, and is expected to register a CAGR of 6.2% during the forecast period. Growth is supported by an expanding elderly population, increasing prevalence of musculoskeletal disorders, and improving access to orthopedic healthcare. Rising healthcare expenditure and modernization of hospitals are enabling greater adoption of advanced joint replacement technologies. Increasing awareness of treatment options for hip disorders and growing demand for improved mobility among older patients are also supporting market development. Continued investments in healthcare infrastructure and orthopedic capabilities are expected to accelerate regional adoption.
Japan represents a significant market for hip replacement implants, supported by its rapidly aging population and established orthopedic healthcare system. Increasing prevalence of age-related joint degeneration and osteoarthritis is creating sustained demand for hip replacement procedures. Healthcare providers are adopting advanced implant designs and surgical approaches to improve mobility and long-term patient outcomes. Japan's focus on medical technology and precision healthcare is also supporting the development and use of sophisticated orthopedic solutions. Growing adoption of minimally invasive and technology-assisted surgical procedures is expected to contribute to continued market development.
China represents a major growth opportunity for hip replacement implants, supported by its large and aging population, rising healthcare expenditure, and improving access to orthopedic care. Increasing prevalence of osteoarthritis and other musculoskeletal conditions is contributing to demand for joint replacement procedures. Hospitals are progressively adopting advanced orthopedic technologies and modern implant systems as healthcare infrastructure expands. Growing awareness of surgical treatment options and increasing focus on mobility and quality of life are further supporting demand. Continued healthcare modernization and expansion of specialized orthopedic services are expected to strengthen market development.
Latin America accounted for a 4.9% share of the Hip Replacement Implants Market, with a value of USD 0.21 billion in 2025. The region is expected to grow at a CAGR of 5.6% during the forecast period. Market development is supported by increasing prevalence of osteoarthritis, an aging population, and gradual improvements in access to orthopedic healthcare. Healthcare facilities are increasingly adopting modern implant technologies and surgical techniques to improve patient outcomes. Growing healthcare investments and expansion of specialized orthopedic centers are also contributing to demand. Rising awareness of joint replacement procedures and improved access to surgical care are expected to support regional market expansion.
Brazil represents a key market for hip replacement implants in Latin America, supported by a large population, increasing incidence of musculoskeletal disorders, and growing demand for orthopedic care. Hospitals and specialized orthopedic centers are increasingly adopting advanced implant systems and improved surgical techniques. Rising awareness of treatment options for hip degeneration and improvements in healthcare access are contributing to market opportunities. The gradual modernization of medical facilities and growing availability of specialized orthopedic services are also supporting adoption. Continued healthcare investments and increasing demand for mobility-restoring procedures are expected to drive market development.
Middle East & Africa accounted for a 3.4% market share, representing USD 0.15 billion in 2025. The region is expected to register a CAGR of 5.1% during the forecast period. Growth is supported by improving healthcare infrastructure, increasing access to orthopedic procedures, and rising prevalence of age-related and degenerative joint conditions. Investments in modern hospitals and specialized surgical centers are enabling greater adoption of advanced implant technologies. Growing healthcare expenditure and increasing awareness of joint replacement procedures are also supporting market development. Continued modernization of healthcare systems and expansion of orthopedic services are expected to create further opportunities.
The UAE's hip replacement implants market is supported by advanced healthcare infrastructure, increasing investment in specialized medical services, and growing demand for orthopedic procedures. Hospitals are increasingly adopting modern implant technologies and advanced surgical techniques to improve patient outcomes and recovery. The country's expanding medical tourism sector and availability of specialized healthcare facilities are also supporting demand for advanced orthopedic treatments. Growing awareness of joint replacement options and improvements in surgical capabilities are contributing to market opportunities. Continued investments in healthcare modernization and specialized orthopedic services are expected to support market development.
The global Hip Replacement Implants market is highly competitive, driven by the increasing prevalence of hip disorders, rising incidence of osteoarthritis and hip fractures, growing geriatric population, and increasing demand for advanced orthopedic procedures. Key players include MatOrtho Limited, Smith+Nephew, OMNIlife science, inc., MicroPort Scientific Corporation, Exactech, Inc., Zimmer Biomet, Medical Device Business Services, Inc., Stryker, Braun Melsungen AG, Enovis Corporation, Aesculap, Inc., Greens Surgicals Pvt. Ltd., NRV OrthoTech Pvt Ltd, HCM ORTHOCARE PVT. LTD, and Sharma Orthopedic. Companies are focusing on advanced implant materials, improved implant durability, minimally invasive surgical technologies, patient-specific solutions, enhanced implant designs, and robotic-assisted orthopedic procedures to strengthen their position in the global Hip Replacement Implants market.
Zimmer Biomet: An Established Market Leader
Zimmer Biomet has strengthened its position through its extensive portfolio of orthopedic products and hip replacement implant solutions designed to address a wide range of patient needs. The company focuses on innovative implant designs, advanced materials, surgical technologies, and solutions that support improved procedural outcomes and long-term implant performance. These capabilities support Zimmer Biomet's strong position in the global Hip Replacement Implants market.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Pacemakers Market Size, Share, Growth, Analysis, Report, 2034
Occlusion Devices Market Size, Share, Growth, Forecast, 2034
Non-Opioid Pain Patches Market Size, Share, Growth, Analysis, 2034
Neurosurgery Device Market Size, Share, Growth, Analysis, 2034
Medical Tubing Market Size, Share, Growth, Analysis, Report, 2034
Medical Protective Clothing Market Size, Share, Growth, Analysis, 2034
We are featured on:
sales@straitsresearch.com